search
Back to results

Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives

Primary Purpose

Hypertension, Non-Adherence, Patient

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Wellth Smartphone App
Targeted Incentives
Non-Restricted Incentives
Sponsored by
Wellth Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension focused on measuring High blood pressure, mobile health, behavioral economics, adherence, non-compliance

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 50+
  • Has hypertension diagnosis
  • Owns a smartphone with sufficient data plan
  • Prescribed at least one daily oral antihypertensive agent
  • Prescription refill data shows <80% adherence in prior 12 months

Exclusion Criteria:

  • Unable or unwilling to provide informed written consent

Sites / Locations

  • UCSD
  • Wellcare
  • Wellth

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Group A. Standard Care ("Control")

Group B. Wellth App ("Treatment 1")

Group C. Wellth App ("Treatment 2") with targeted rewards

Group D. Wellth App ("Treatment 3") with non-targeted rewards

Arm Description

Does not receive Wellth app.

Receives Wellth app without additional financial rewards tied to adherence.

Receives Wellth app with additional ability to earn up to $150 rewards usable at local pharmacies for using the app to track adherence.

Receives Wellth app with additional ability to earn up to $150 rewards usable at many stores for using the app to track adherence.

Outcomes

Primary Outcome Measures

Medication adherence
Improve medication adherence, as measured by prescription fill data or app adherence, in either Group C or D receiving financial incentives tied to adherence, as compared with Groups A or B receiving standard care or app with no additional incentives, respectively.

Secondary Outcome Measures

Blood Pressure Reduction
Reduce BP in either Group C or D as compared to group A or B, as measured by data read from photos of weekly home BP measurement readouts submitted via the app
Blood Pressure Reduction
Compare BP across Groups B, C, and D as measured by data provided from photos of weekly home BP measurement readouts submitted via the app
Compare the effectiveness of two types of incentives for blood pressure
Compare the difference(s) in Groups C and D for blood pressure reading levels submitted via the app
Compare the effectiveness of two types of incentives for medication adherence
Compare the difference(s) in Groups C and D for adherence to prescribed medication (via the app and/or prescription data).
Compare the effectiveness of two types of incentives for self-monitoring adherence
Compare the difference(s) in Groups C and D for blood pressure self-monitoring adherence through the app.
Compare the effectiveness of two types of incentives for meal logging adherence
Compare the difference(s) in Groups C and D for meal logging adherence monitored and submitted through the app.
Compare average incentive values earned by participants in group(s) C and D
Evaluate and compare the average earned incentive values for participants in groups C and D

Full Information

First Posted
August 27, 2019
Last Updated
December 21, 2020
Sponsor
Wellth Inc.
Collaborators
University of California, San Diego
search

1. Study Identification

Unique Protocol Identification Number
NCT04075045
Brief Title
Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives
Official Title
Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives: Using New Technologies and Insights From Behavioral Economics to Increase the Effectiveness of Behavioral Change
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
September 2, 2019 (Actual)
Primary Completion Date
July 23, 2020 (Actual)
Study Completion Date
July 23, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wellth Inc.
Collaborators
University of California, San Diego

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypertension is the leading risk factor for cardiovascular disease, global mortality, and ranks third among the causes of disability. Treatment of hypertension is relatively straightforward, but patient adherence to long-term self-care strategies is problematically low. Three important behaviors that individuals can adhere to in order to help lower their BP are 1) Taking medications as prescribed by a physician, 2) Monitoring BP at home, and 3) Limiting dietary sodium intake. Adherence to these behaviors is problematic and currently ranges from 25% to 50%; the present Phase I STTR study is aimed at addressing the behavioral barriers for adherence to these three activities with the help of mobile technology. In particular, this STTR will develop and test an incentive program delivered through a mobile health app to increase adherence to prescribed BP control regimens and precipitate reduction in BP.
Detailed Description
Hypertension, or sustained systolic and diastolic blood pressure (BP) of 140 and 90 mmHg or higher, is among the most frequently encountered conditions in primary care in the U.S. The estimated prevalence is 30% among all U.S. adults and increases with age, reaching 65% for adults over 65 years of age. Hypertension is also the leading risk factor for cardiovascular disease, global mortality, and ranks third among the causes of disability. Treatment of hypertension is relatively straightforward, but patient adherence to long-term self-care strategies is problematically low. Three important behaviors that individuals can adhere to in order to help lower their BP are 1) Taking medications as prescribed by a physician, 2) Monitoring BP at home, and 3) Limiting dietary sodium intake. Adherence to these behaviors is problematic and currently ranges from 25% to 50%; the present Phase I STTR study is aimed at addressing the behavioral barriers for adherence to these three activities with the help of mobile technology. In particular, this STTR will develop and test an incentive program delivered through a mobile health app to increase adherence to prescribed BP control regimens and precipitate reduction in BP. The target participants for the test are adults with clinically diagnosed hypertension. The product to be developed is a mobile health app for patient smartphones, which delivers reminder triggers and immediate behavioral reinforcement through incentives to establish long-term habits. The incentives in each treatment arm are either purely financial or framed to target specific "mental accounts" to maximize the behavioral effectiveness of the intervention. The specific aims of the study are to (1) Demonstrate feasibility of combining behavioral economics with state-of-the-art telehealth technology to deliver an optimal incentive strategy to the specific group of patients to promote adherence and reduce BP, and (2) Compare the effectiveness of two types of incentives, i.e., pure financial and mental accounting, on BP and adherence to all three self-care activities: medications, BP monitoring, and meal logging. Phase II will test the efficacy of this approach in a larger and more diverse population to search for statistically and clinically significant improvements in blood pressure resulting from use of the app with the optimal incentive strategy. Initial customers are health insurers and risk-bearing hospital systems (e.g. those with value-based reimbursement models), who are fiscally responsible for healthcare expenses for large numbers of patients with poorly controlled BP.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Non-Adherence, Patient
Keywords
High blood pressure, mobile health, behavioral economics, adherence, non-compliance

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Approximately 500 participants will be randomized into four groups (n=125 per group). Some groups will receive the Wellth app providing reminders and regimen tracking, and some groups may have the opportunity to earn financial rewards for their adherence.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
97 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A. Standard Care ("Control")
Arm Type
No Intervention
Arm Description
Does not receive Wellth app.
Arm Title
Group B. Wellth App ("Treatment 1")
Arm Type
Experimental
Arm Description
Receives Wellth app without additional financial rewards tied to adherence.
Arm Title
Group C. Wellth App ("Treatment 2") with targeted rewards
Arm Type
Experimental
Arm Description
Receives Wellth app with additional ability to earn up to $150 rewards usable at local pharmacies for using the app to track adherence.
Arm Title
Group D. Wellth App ("Treatment 3") with non-targeted rewards
Arm Type
Experimental
Arm Description
Receives Wellth app with additional ability to earn up to $150 rewards usable at many stores for using the app to track adherence.
Intervention Type
Behavioral
Intervention Name(s)
Wellth Smartphone App
Intervention Description
Patients will receive the app that provides reminders to adhere to their self-care regimen and ability to track their daily adherence via photos of the self-care related items (medications, blood pressure cuff, meals).
Intervention Type
Behavioral
Intervention Name(s)
Targeted Incentives
Intervention Description
Participants may earn up financial rewards tied to their adherence. The rewards are only usable at pharmacies.
Intervention Type
Behavioral
Intervention Name(s)
Non-Restricted Incentives
Intervention Description
Participants may earn up financial rewards tied to their adherence. The rewards are only usable at most stores, except for prohibited purchases such as alcohol, tobacco, or firearms, and is not redeemable for cash.
Primary Outcome Measure Information:
Title
Medication adherence
Description
Improve medication adherence, as measured by prescription fill data or app adherence, in either Group C or D receiving financial incentives tied to adherence, as compared with Groups A or B receiving standard care or app with no additional incentives, respectively.
Time Frame
Ninety (90) days
Secondary Outcome Measure Information:
Title
Blood Pressure Reduction
Description
Reduce BP in either Group C or D as compared to group A or B, as measured by data read from photos of weekly home BP measurement readouts submitted via the app
Time Frame
Ninety (90) days.
Title
Blood Pressure Reduction
Description
Compare BP across Groups B, C, and D as measured by data provided from photos of weekly home BP measurement readouts submitted via the app
Time Frame
Ninety (90) days.
Title
Compare the effectiveness of two types of incentives for blood pressure
Description
Compare the difference(s) in Groups C and D for blood pressure reading levels submitted via the app
Time Frame
Ninety (90) days.
Title
Compare the effectiveness of two types of incentives for medication adherence
Description
Compare the difference(s) in Groups C and D for adherence to prescribed medication (via the app and/or prescription data).
Time Frame
Ninety (90) days.
Title
Compare the effectiveness of two types of incentives for self-monitoring adherence
Description
Compare the difference(s) in Groups C and D for blood pressure self-monitoring adherence through the app.
Time Frame
Ninety (90) days.
Title
Compare the effectiveness of two types of incentives for meal logging adherence
Description
Compare the difference(s) in Groups C and D for meal logging adherence monitored and submitted through the app.
Time Frame
Ninety (90) days.
Title
Compare average incentive values earned by participants in group(s) C and D
Description
Evaluate and compare the average earned incentive values for participants in groups C and D
Time Frame
Ninety (90) days.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 50+ Has hypertension diagnosis Owns a smartphone with sufficient data plan Prescribed at least one daily oral antihypertensive agent Prescription refill data shows <80% adherence in prior 12 months Exclusion Criteria: Unable or unwilling to provide informed written consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Uri Gneezy, Ph.D.
Organizational Affiliation
University of California, San Diego
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCSD
City
San Diego
State/Province
California
ZIP/Postal Code
92093
Country
United States
Facility Name
Wellcare
City
New York
State/Province
New York
ZIP/Postal Code
10004
Country
United States
Facility Name
Wellth
City
New York
State/Province
New York
ZIP/Postal Code
11101
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24171916
Citation
Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013 Oct;(133):1-8.
Results Reference
background
PubMed Identifier
15652604
Citation
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15-21;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1.
Results Reference
background
PubMed Identifier
15908846
Citation
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005 Jun;43(6):521-30. doi: 10.1097/01.mlr.0000163641.86870.af.
Results Reference
background
PubMed Identifier
23604493
Citation
Ostchega Y, Berman L, Hughes JP, Chen TC, Chiappa MM. Home blood pressure monitoring and hypertension status among US adults: the National Health and Nutrition Examination Survey (NHANES), 2009-2010. Am J Hypertens. 2013 Sep;26(9):1086-92. doi: 10.1093/ajh/hpt054. Epub 2013 Apr 19.
Results Reference
background
PubMed Identifier
15194600
Citation
Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004 Jul 17;329(7458):145. doi: 10.1136/bmj.38121.684410.AE. Epub 2004 Jun 11. Erratum In: BMJ. 2004 Aug 28;329(7464):499.
Results Reference
background
Citation
US Food & Drug Administration. FDA issues draft guidance to food industry for voluntarily reducing sodium in processed and commercially prepared food. 2016.
Results Reference
background
PubMed Identifier
23771844
Citation
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14. No abstract available.
Results Reference
background

Learn more about this trial

Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives

We'll reach out to this number within 24 hrs